Target Name: RSU1
NCBI ID: G6251
Review Report on RSU1 Target / Biomarker Content of Review Report on RSU1 Target / Biomarker
RSU1
Other Name(s): rsu-1 | Ras suppressor protein 1 variant 3 | OTTHUMP00000019218 | FLJ31034 | Ras suppressor protein 1 variant 2 | Rsu-1 | RSP1 | Ras suppressor protein 1 variant 1 | Ras suppressor protein 1, transcript variant 1 | RSU1_HUMAN | RSU1 variant 1 | OTTHUMP00000019217 | Ras suppressor protein 1 | Ras suppressor protein 1 (isoform 1) | RSP-1 | ras suppressor protein 1 variant 5

Exploring The Biology and Potential Drug Targets of RSU-1

RSU-1 (Research Support Unit 1) is a protein that is expressed in various tissues of the body, including the brain, heart, and liver. It is a member of the superfamily of RNA-protein hybrids, which are involved in various cellular processes. One of the unique features of RSU-1 is its ability to interact with small molecules, such as drugs, toxins, and diseases, making it an attractive target for researchers to study. In this article, we will explore the biology and potential drug targets of RSU-1.

Structure and Expression

RSU-1 is a 25kDa protein that consists of 195 amino acid residues. It has a characteristic Rossmann-fold structure that is commonly seen in proteins that interact with small molecules. The Rossmann-fold is a type of hydrogen bonding network that is formed by the interaction of amino acids. It allows RSU-1 to bind to small molecules with high affinity and stability.

RSU-1 is expressed in various tissues of the body, including the brain, heart, and liver. It is highly expressed in the brain, with highest levels of expression found in the prefrontal cortical cortex. It is also expressed in the heart and liver , with lower levels of expression. The expression of RSU-1 is regulated by various factors, including DNA binding, RNA translation, and post-translational modification.

Function and Interaction

RSU-1 plays a role in various cellular processes, including cell signaling, DNA replication, and metabolism. It is involved in the regulation of DNA binding by RNA, which allows it to interact with specific small molecules. It is also involved in the regulation of protein translation, which plays a role in the production of various proteins.

RSU-1 has been shown to interact with a variety of small molecules, including drugs and toxins. For example, RSU-1 has been shown to interact with the drug clozapine, which is a treatment for schizophrenia. Clozapine inhibits the action of dopamine in the brain, leading to reduced symptoms of psychosis. RSU-1 has also been shown to interact with the neurotoxin BMAA, which is found in various tissues, including the brain, and has been linked to the development of neurodegenerative diseases.

Drug Targets

RSU-1 has potential as a drug target due to its ability to interact with small molecules. Various studies have shown that RSU-1 can be targeted by small molecules, including drugs and toxins. One of the most promising compounds that has been shown to interact with RSU-1 is the drug BMAA, which has been shown to induce neurotoxicity in various tissues.

An inhibitor of RSU-1 has been shown to be effective in reducing the neurotoxicity of BMAA. The inhibitor, peronitriamide (PNA), has been shown to reduce the neurotoxicity of BMAA in rat models of neurotoxicity. PNA works by inhibiting the interaction between RSU-1 and BMAA, which allows it to reduce the neurotoxicity of BMAA.

Another compound that has been shown to interact with RSU-1 is the drug rapamycin. Rapamycin is an inhibitor of the mTOR pathway, which is involved in cell signaling. It has been shown to interact with RSU-1 and inhibit its activity.

Conclusion

RSU-1 is a protein that has been shown to interact with various small molecules, including drugs and toxins. Its unique Rossmann-fold structure and high expression in the brain make it an attractive target for researchers to study. The potential drug targets for RSU -1 include the inhibitor BMAA and the inhibitor rapamycin. Further studies are needed to fully understand the biology and potential drug targets of RSU-1.

Protein Name: Ras Suppressor Protein 1

Functions: Potentially plays a role in the Ras signal transduction pathway. Capable of suppressing v-Ras transformation in vitro

The "RSU1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RSU1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

RSU1P2 | RTBDN | RTCA | RTCB | RTEL1 | RTEL1-TNFRSF6B | RTF1 | RTF2 | RTKN | RTKN2 | RTL1 | RTL10 | RTL3 | RTL4 | RTL5 | RTL6 | RTL8A | RTL8B | RTL8C | RTL9 | RTN1 | RTN2 | RTN3 | RTN4 | RTN4IP1 | RTN4R | RTN4RL1 | RTN4RL2 | RTP1 | RTP2 | RTP3 | RTP4 | RTP5 | RTRAF | RTTN | RUBCN | RUBCNL | RUFY1 | RUFY2 | RUFY3 | RUFY4 | RUNDC1 | RUNDC3A | RUNDC3A-AS1 | RUNDC3B | RUNX1 | RUNX1-IT1 | RUNX1T1 | RUNX2 | RUNX2-AS1 | RUNX3 | RUNX3-AS1 | RUSC1 | RUSC1-AS1 | RUSC2 | RUSF1 | RUVBL1 | RUVBL1-AS1 | RUVBL2 | RWDD1 | RWDD2A | RWDD2B | RWDD3 | RWDD3-DT | RWDD4 | RXFP1 | RXFP2 | RXFP3 | RXFP4 | RXRA | RXRB | RXRG | RXYLT1 | Ryanodine receptor | RYBP | RYK | RYR1 | RYR2 | RYR3 | RZZ complex | S100 Calcium Binding Protein | S100A1 | S100A10 | S100A11 | S100A11P1 | S100A12 | S100A13 | S100A14 | S100A16 | S100A2 | S100A3 | S100A4 | S100A5 | S100A6 | S100A7 | S100A7A | S100A7L2 | S100A7P1 | S100A8 | S100A9